NASDAQ:STOK - Stoke Therapeutics News Headlines

$30.87

+0.87 (+2.90 %)

(As of 08/18/2019 02:58 PM ET)

Add

Today's Range

$28.68

Now: $30.87▼

$31.76

50-Day Range

$22.40

MA: $26.63▼

$30.92

52-Week Range

$22.01

Now: $30.87▼

$31.97

Volume101,500 shs

Average Volume99,302 shs

Market Capitalization$971.17 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Source:

Date	Headline
	Stoke Therapeutics (NASDAQ:STOK) Issues Quarterly Earnings Results, Misses Estimates By $0.58 EPS www.americanbankingnews.com - August 15 at 11:20 AM
	Cowen Reaffirms Buy Rating for Stoke Therapeutics (NASDAQ:STOK) www.americanbankingnews.com - August 15 at 7:17 AM
	Stoke Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update finance.yahoo.com - August 14 at 11:41 AM
	Stoke Therapeutics Granted FDA Orphan Drug Designation for STK-001, an Investigational New Treatment for Dravet Syndrome finance.yahoo.com - August 6 at 3:21 PM
	IPO Pops Proliferate as Two More Firms Surge 50% finance.yahoo.com - June 28 at 3:15 PM
	Stoke Therapeutics shares soar 46% in trading debut finance.yahoo.com - June 24 at 3:16 PM
	Stoke Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares finance.yahoo.com - June 24 at 3:16 PM

This page was last updated on 8/18/2019 by MarketBeat.com Staff

Headlines